Journal of Clinical Endocrinology & Metabolism
Sermorelin: a review of its use in the diagnosis and treatment of growth hormone deficiency
1999 · PMID 10543625
Walker RF.
View sourceCompound information
Technical specifications for laboratory reference
Molecular profile
GHRH(1-29)amide — the biologically active N-terminal fragment of growth hormone-releasing hormone, used in GHRH receptor research.
Storage requirements
Lyophilized (powder)
−20°C · up to 24 months
Reconstituted
2–8°C · up to 21 days
Literature
Peer-reviewed research for laboratory background
Journal of Clinical Endocrinology & Metabolism
1999 · PMID 10543625
Walker RF.
View sourceCitations are provided for research background only. Peptide Club materials are sold for laboratory research use — not for human or veterinary consumption. References do not constitute product claims.

Secretagogue Compound
GHRH(1-29)amide — the biologically active N-terminal fragment of growth hormone-releasing hormone, used in GHRH receptor research.
Est. delivery Mon, Sep 14–Fri, Sep 18 · COA included · Same-day ship before 2PM PT
Apple Pay · Google Pay · Visa · Amex · Discover
Quality documentation
Third-party tested · batch-specific results
99.9%purity
Passed full QC panel
Batch COA PDF not linked yet for this variant. Email info@peptideclub.com or browse all COAs.
99.9%purity
Passed full QC panel
99.9%purity
Passed full QC panel
Batch COA PDF not linked yet for this variant. Email info@peptideclub.com or browse all COAs.
Batch COA PDF not linked yet for this variant. Email info@peptideclub.com or browse all COAs.